An Interactive Decision Support Tool: Treatment Options From 5 Experts for People With Multiple Myeloma
Did you recently receive a diagnosis of multiple myeloma, or has your multiple myeloma come back or progressed? Answer a few multiple-choice questions in this interactive tool to get treatment suggestions from 5 experts to discuss with your doctor.
Mark and Judy Mullins Professor of Hematological Malignancies Chair, Myeloma Amyloidosis Dysproteinemia Group Consultant, Division of Hematology Mayo Clinic Rochester, Minnesota
Suzanne Lentzsch, MD, PhD
Professor of Medicine Division of Hematology/Oncology Columbia University Medical Center New York, New York
Sagar Lonial, MD, FACP
Chair and Professor Department of Hematology and Medical Oncology Anne and Bernard Gray Family Chair in Cancer Chief Medical Officer Winship Cancer Institute Emory University School of Medicine Atlanta, Georgia
Joseph Mikhael, MD, MEd, FRCPC, FACP
Professor Applied Cancer Research and Drug Discovery Translational Genomics Research Institute Phoenix, Arizona Chief Medical Officer International Myeloma Foundation HonorHealth Research Institute Scottsdale, Arizona
Saad Z. Usmani, MD, MBA, FACP
Chief of Myeloma Service Memorial Sloan Kettering Cancer Center Professor Weill Cornell Medical College, Cornell University New York, New York
Provided by Clinical Care Options, LLC
Supported by educational grants from AbbVie, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Karyopharm Therapeutics and Regeneron Pharmaceuticals, Inc.
Bristol Myers Squibb
Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
Regeneron Pharmaceuticals, Inc
Select date of attendance
Accept Terms and Conditions
Leaving The Site